Versigent (VGNT) director granted 5,168 Ordinary Shares as equity award

Rhea-AI Filing Summary

Versigent PLC director Amy E. Alving received a share grant of 5,168 Ordinary Shares. The award was recorded at a price of $0.00 per share, indicating a compensation-related grant rather than a market purchase. Following this acquisition, she directly holds 5,168 Ordinary Shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Alving Amy E

Role null

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	5,168	$0.00	--

Holdings After Transaction: Ordinary Shares — 5,168 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 5,168 shares Grant price: $0.00 per share Shares held after grant: 5,168 shares

3 metrics

Shares granted 5,168 shares Ordinary Shares granted to director Amy E. Alving

Grant price $0.00 per share Reported transaction price for the share award

Shares held after grant 5,168 shares Total direct holdings following the transaction

Key Terms

Ordinary Shares, Grant, award, or other acquisition, Form 4

3 terms

Ordinary Shares financial

"security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alving Amy E

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

SCHAFFHAUSEN SWITZERLAND 8200

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/22/2026		A		5,168	A	$0	5,168	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Janis Acosta, Attorney-in-fact for Amy Alving	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Versigent PLC (VGNT) director Amy E. Alving report on this Form 4?

Director Amy E. Alving reported receiving a grant of 5,168 Versigent PLC Ordinary Shares. The transaction was coded as an acquisition award at $0.00 per share, reflecting a compensation-related equity grant rather than an open-market transaction.

How many Versigent PLC (VGNT) shares did Amy E. Alving acquire in this transaction?

Amy E. Alving acquired 5,168 Ordinary Shares of Versigent PLC in this transaction. The filing classifies it as a grant or award, adding these shares to her direct holdings rather than reflecting a market purchase or sale.

What was the price per share for Amy E. Alving’s Versigent PLC (VGNT) share grant?

The reported price per share for Amy E. Alving’s grant was $0.00. This indicates the shares were issued as part of a compensation or award arrangement, not bought on the open market at a cash purchase price.

What are Amy E. Alving’s Versigent PLC (VGNT) holdings after this Form 4 transaction?

After the grant, Amy E. Alving directly holds 5,168 Ordinary Shares of Versigent PLC. The Form 4 shows this total in the “shares following transaction” field, reflecting her updated direct ownership position after the award.

Is Amy E. Alving’s Versigent PLC (VGNT) transaction a buy or a compensation grant?

The transaction is a compensation-related grant, not a market buy. It is coded as “A” for grant, award, or other acquisition, with 5,168 Ordinary Shares received at a reported price of $0.00 per share.